Journal of Medical Physics
ORIGINAL ARTICLE
Year
: 2019  |  Volume : 44  |  Issue : 3  |  Page : 176--184

Electronic portal imaging device-based three-dimensional volumetric dosimetry for intensity-modulated radiotherapy pretreatment quality assurance


Manikandan Arjunan1, Sureka Chandra Sekaran1, Biplab Sarkar2, Saran Kumar Manavalan3 
1 Department of Medical Physics, Bharathiar University, Coimbatore, Tamil Nadu, India
2 Department of Radiation Oncology, Manipal Hospital, Delhi, India
3 Department of Radiation Oncology, Nagarjuna Hospital, Vijayawada, Andhra Pradesh, India

Correspondence Address:
Dr. Sureka Chandra Sekaran
Department of Medical Physics, Bharathiar University, Coimbatore - 641 046, Tamil Nadu
India

Aim: This study aimed at evaluating the efficacy of treatment planning system (TPS)-based heterogeneity correction for two- and three-dimensional (2D and 3D) electronic portal imaging device (EPID)-based pretreatment dose verification. An experiment was conducted on the EPID back-projection technique and intensity-modulated radiotherapy (IMRT). Materials and Methods: Treatment plans were delivered in EPID without a patient to obtain the fluence pattern (FEPID). A heterogeneity correction plane (Fhet) for an open beam of 30 cm × 30 cm was extracted from the TPS. The heterogeneity-corrected measured fluence is developed by matrix element multiplication (FResultant= FEPID× Fhet). Further planes were summed to develop a 3D dose distribution and exported to the TPS. Dose verifications for 2D and 3D were carried out with the corresponding TPS values using 2D gamma analysis (ɣ) and dose volume histogram (DVH) comparison, respectively. Totally, 33 patients (17 head–neck and 16 thorax cases) were evaluated in this study. Results: The head–neck and thorax plans show a 3-mm-distance to agreement (DTA) 3% DD gamma passing of 96.3% ± 2.0% and 95.4% ± 1.8% points, respectively, between FTPS and FResultant. The comparison of the uncorrected measured fluence (FEPID) with FTPS reveals a gamma passing of 82.2% ± 7.3% and 80.4% ± 8.6% for head–neck and thorax cases, respectively. A total of 87 out of the 102 head–neck and thorax beams exhibit a planner gamma passing of 97.6% ± 2.1%. In the 3D-DVH comparison of thorax and head–neck cases, D5% for planning target volume were −0.5% ± 2.2% and −2.1% ± 3.5%, respectively; D95% varies as 1.0% ± 2.7% and 1.4% ± 1.1% between TPS calculated and heterogeneity-corrected-EPID-based dose reconstruction. Conclusion: The novel TPS-based heterogeneity correction can improve the 2D and 3D EPID-based back projection technique. Structures with large heterogeneities can also be handled using the proposed technique.


How to cite this article:
Arjunan M, Sekaran SC, Sarkar B, Manavalan SK. Electronic portal imaging device-based three-dimensional volumetric dosimetry for intensity-modulated radiotherapy pretreatment quality assurance.J Med Phys 2019;44:176-184


How to cite this URL:
Arjunan M, Sekaran SC, Sarkar B, Manavalan SK. Electronic portal imaging device-based three-dimensional volumetric dosimetry for intensity-modulated radiotherapy pretreatment quality assurance. J Med Phys [serial online] 2019 [cited 2019 Nov 17 ];44:176-184
Available from: http://www.jmp.org.in/article.asp?issn=0971-6203;year=2019;volume=44;issue=3;spage=176;epage=184;aulast=Arjunan;type=0